Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health
Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health
The desogestrel (150 mg) in combination with ethinyl estradiol (EE, 30 mg) is known as
 Marvelon in European countries. Previous studies revealed that the Marvelon is good and safe
 for women. As a study from Thailand showed that the Marvelon to be effective and acceptable
 in Thai women. Moreover compared to Caucasian women, the incidences of irregular bleeding and
 side effects were apparently lower in these Asian women . Although Marvelon was used in many
 countries but it's efficacy didn't reported among Iranian women.
Inclusion Criteria:

 being on married, being within 18-40 years old, having normal Body mass index (ranged from
 20 to 27 kg/m2), don't use any OCP during 3 months ago, having a normal menstruation cycle
 for the last three cycles, having at least one of following mental and behavioural symptoms
 ( Fatigue, mood changes, lack of energy, irritability, aggression, depression, decreased
 concentration, decreased social relationships, having a greed and increased appetite to
 eating food), having at least one of following physical symptoms (Breast sensitivity,
 swelling and flatulence) and women tend to use OCP for six consecutive months.

 Exclusion Criteria:

 pregnancy, having Anorexia or Bulimia, doing breastfeeding, smoke cigarette, Taking
 sleeping pills more than 3 days per month, Injection estrogen, progesterone or androgen
 during the past 3 months, Contraindications for OCP (including: thrombophlebitis - Severe
 liver disease - cerebrovascular accident and heart disease - unexplained uterine bleeding -
 lupus - breast cancer - migraines - sickle cell anemia - Epilepsy - gallbladder disease -
 kidney problems - varicocele and family history thrombosis).